Xiaoxue Lai
-
- Immune cells in cancer 7
- Immunotherapy and Immune Responses 2
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
-
- Nanoplatforms for cancer theranostics 5
-
- Cancer Immunotherapy and Biomarkers 3
-
- Cell Adhesion Molecules Research 2
-
- Cancer, Stress, Anesthesia, and Immune Response 2
-
- Inflammasome and immune disorders 2
- Journals
- ACS Nano (2 papers)Journal of Controlled Release (2 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- China
In The Last Decade
Xiaoxue Lai
10 papers receiving 330 citations
Peers
Comparison fields: 5 of 82
- Immunology 126
- Developmental Neuroscience 14
- Biomaterials 42
- Biomedical Engineering 89
- Neurology 16
Countries citing papers authored by Xiaoxue Lai
This map shows the geographic impact of Xiaoxue Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxue Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxue Lai more than expected).
Fields of papers citing papers by Xiaoxue Lai
This network shows the impact of papers produced by Xiaoxue Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxue Lai. The network helps show where Xiaoxue Lai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoxue Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 28 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 14 | |
| 5 | 2021 | 34 | |
| 6 | 2021 | 15 | |
| 7 | 2021 | 49 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 31 | |
| 11 | 2019 | 142 |
About Xiaoxue Lai
Xiaoxue Lai is a scholar working on Immunology, Immunology and Allergy and Oncology, having authored 11 papers that have together received 333 indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Nanoplatforms for cancer theranostics (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Cell Adhesion Molecules Research (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Immunology (126 citations), Developmental Neuroscience (14 citations) and Biomaterials (42 citations). Xiaoxue Lai has collaborated with scholars based in China. Frequent co-authors include Yihui Deng, Yanzhi Song, Shuo Wang, Xinrong Liu, Shuo Wang, Miao Hu, Meng Chen, Xiang Luo, Shuo Wang and Cong Li. Their work appears in journals such as ACS Nano, Journal of Controlled Release and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.